This photo shows the head office of the American multinational pharmaceutical corporation Pfizer in New York.
Gulf Today Report
Pfizer's COVID-19 vaccine faces one final hurdle as two dozen independent experts convened by the Food and Drug Administration (FDA) will spend on Thursday debating the issue during a livestreamed public event, an exercise in transparency unmatched by any other regulatory agency.
At the end of the day Pfizer races to become the first shot greenlighted in the US: a panel of experts who will scrutinise the company’s data for any red flags.
The members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) will hold a vote on whether or not to recommend that the FDA issues an emergency use authorisation (EUA).
Image only for representation
Thursday’s meeting of the Food and Drug Administration’s vaccine advisory panel is likely the last step before a US decision to begin shipping millions of doses of the shot, which has shown strong protection against the coronavirus.
The FDA panel functions like a science court that will pick apart the data and debate — in public and live-streamed — whether the shot is safe and effective enough to be cleared for emergency use. The non-government experts specialize in vaccine development, infectious diseases and medical statistics. The FDA is expected to follow the committee’s advice, although it is not required to do so.
The FDA’s decision comes as the coronavirus continues surging across much of the world, claiming more than 1.5 million lives, including more than 289,000 in the US.Hanging over the meeting is a warning from U.K. officials that people with a history of serious allergic reactions shouldn’t get the vaccine. Government officials there are investigating two reports of reactions that occurred when the country began mass vaccinations.
"The Saudi Food and Drug Authority (SFDA)... has approved the registration of Pfizer-BioNTech COVID-19 vaccine in the kingdom of Saudi Arabia," it said in a statement released by the official Saudi Press Agency.
The vaccine will be used against coronavirus in the Sultanate.
Amid a torrent of negative and worrisome news related to COVID-19 pandemic globally, Moderna Inc’s claim that its experimental COVID-19 vaccine, the first to be tested in the United States, has produced protective antibodies in a small group of healthy volunteers injects hope and some relief.
When pharmaceutical company Moderna issued a press release about the promising results of its Phase I clinical trial for a coronavirus vaccine, the media and the markets went wild. The New York Times ran a story that went viral on Twitter, racking up millions of views as social media influencers and doctors alike shared it far and wide. Moderna’s stock price shot up 20 per cent and several peer companies like Novavax rallied even higher at more than 30 per cent.
Official records reveal that the company’s accounting department has discovered the defendant’s illegal actions after finding forged payment receipts.
After investigating the roll’s content, police found 250g of cocaine which the defendant was attempting to smuggle inside the country.
In talks with Sri Lankan President Gotabaya Rajapaksa on Wednesday, Imran highlighted Buddhist heritage sites in Pakistan and stressed the building of cultural ties, the Pakistan embassy said in a statement. I